Fundraising Fox

Bonusbiogroup

1 known investors

bonusbiogroup.com β†—

Bonus Biogroup is a clinical-stage biotechnology company developing tissue engineering and cell therapy products for unmet medical needs related to tissue damage, inflammation, and immune response. Its investigational products include MesenCure, an allogeneic cell therapy targeting inflammation, and BonoFill, a tissue-engineered bone graft for orthopedic and maxillofacial bone defects.

BiotechLongevityMedical Devices

Founders & leadership

DS
Dr. Shai MeretzkiCEO and Founder

Investors Β· 1

Frequently asked questions

What does Bonusbiogroup do?
Bonus Biogroup is a clinical-stage biotechnology company developing tissue engineering and cell therapy products for unmet medical needs related to tissue damage, inflammation, and immune response. Its investigational products include MesenCure, an allogeneic cell therapy targeting inflammation, and BonoFill, a tissue-engineered bone graft for orthopedic and maxillofacial bone defects.
Who founded Bonusbiogroup?
Bonusbiogroup was founded by Dr. Shai Meretzki.
Who are Bonusbiogroup's investors?
Bonusbiogroup's investors include SIBF (Southern Israel Bridging Fund) VC.